Advanced in Antisynthetase Syndrome

Stephane Dominique

CHU Rouen
Rouen, FR 
Advanced in Antisynthetase Syndrome
CHU Rouen
Rouen, FR 
OverviewLocationsClinical Research

Overview

Stephane Dominique practices in Rouen, France. Ms. Dominique is rated as an Advanced expert by MediFind in the treatment of Antisynthetase Syndrome. Her top areas of expertise are Langerhans Cell Histiocytosis, Interstitial Lung Disease, Acute Interstitial Pneumonia, Cystic Fibrosis, and Endoscopy.

Her clinical research consists of co-authoring 64 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 7 articles in the study of Antisynthetase Syndrome.

Gender
Female

Locations

CHU Rouen
Rouen, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Observational Study of Glucose Tolerance Abnormalities in Patient With Cystic Fibrosis Homozygous for Phe 508 Del CFTR Treated by Lumacaftor-Ivacaftor
Observational Study of Glucose Tolerance Abnormalities in Patient With Cystic Fibrosis Homozygous for Phe 508 Del CFTR Treated by Lumacaftor-Ivacaftor
Enrollment Status: Completed
Publish Date: November 24, 2021
Intervention Type: Drug
Evaluation of an Antibiotic Treatment With 14 Days of Intravenous Tobramycin Versus the Same Antibiotic Associated With 5 Days of Intravenous Tobramycin Followed by Tobramycin Aerosol for 9 Days in Cystic Fibrosis.
Evaluation of an Antibiotic Treatment With 14 Days of Intravenous Tobramycin Versus the Same Antibiotic Associated With 5 Days of Intravenous Tobramycin Followed by Tobramycin Aerosol for 9 Days in Cystic Fibrosis.
Enrollment Status: Terminated
Publish Date: September 05, 2021
Intervention Type: Drug
Study Drugs: Tobramycin, Nebcin
Study Phase: Phase 3
View 1 Less Clinical Trial

63 Total Publications

Clinical phenotype of adult-onset systemic histiocytosis harboring BRAF in-frame deletions.
Clinical phenotype of adult-onset systemic histiocytosis harboring BRAF in-frame deletions.
Journal: Haematologica
Published: March 04, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Dominique's expertise for a condition
ConditionClose
      View All 8 Advanced Conditions
      View All 17 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile